[HTML][HTML] The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot, A Bourredjem… - Journal of translational …, 2020 - Springer
Background Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
[HTML][HTML] The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot… - Journal of …, 2020 - … -medicine.biomedcentral.com
Although immune modulation is a promising therapeutic avenue in coronavirus disease
2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar …
2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar …
[PDF][PDF] The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot, A Bourredjem, M Nguyen… - 2020 - academia.edu
Background: Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID‑19), the most relevant targets remain to be found. COVID‑19 has …
disease 2019 (COVID‑19), the most relevant targets remain to be found. COVID‑19 has …
[PDF][PDF] The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot, A Bourredjem, M Nguyen… - 2020 - scholar.archive.org
Background: Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID‑19), the most relevant targets remain to be found. COVID‑19 has …
disease 2019 (COVID‑19), the most relevant targets remain to be found. COVID‑19 has …
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot… - Journal of …, 2020 - search.proquest.com
Background Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.
M Blot, JB Bour, JP Quenot, A Bourredjem… - Journal of …, 2020 - go.gale.com
Background Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
[HTML][HTML] The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot, A Bourredjem… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
[PDF][PDF] The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot, A Bourredjem, M Nguyen… - 2020 - scienceopen.com
Background: Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID‑19), the most relevant targets remain to be found. COVID‑19 has …
disease 2019 (COVID‑19), the most relevant targets remain to be found. COVID‑19 has …
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.
M Blot, JB Bour, JP Quenot, A Bourredjem… - Journal of …, 2020 - europepmc.org
Background Although immune modulation is a promising therapeutic avenue in coronavirus
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …
disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has …